Filter results

Pharmaceutical Industry Reports

By Geography
By Sector
By Publication Type
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%
Showing
1-20 of 98
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

BMI View: Despite a slowdown in the Algerian economy due to low oil prices, the country's pharmaceutical and healthcare markets are expected to sustain their positive growth trajectory over a multi-quarter horizon. The health ...
$1,295.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

BMI View: Angola is emerging from a long civil war, which ha s resulted in years of neglect of its healthcare sector. Whilst the government is taking positive measures to address a lack of hospitals ...
$1,295.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

BMI View: Robust pharmaceutical and healthcare market growth in Argentina will lead to improved opportunities for drugmakers over the next 10 years. Despite the government 's increased focus on domestic pharmaceutical production, Argentina will retain its ...
$1,295.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

BMI View: As the Australian government continues to focus on cost containment while at the same time increasing the population's access to innovative medicines, companies will increasingly need to justify the price of their ...
$1,295.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

BMI View: While we view the Austrian pharmaceutical and healthcare market as relatively stable and insulated from sudden downgrades, we highlight that certain economic factors pose a risk to public spending in particular. However, the ...
$1,295.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

BMI View: Bahrain's healthcare sector will become increasingly privatised following the exclusion of expatriates from the public health system and the eventual implementation of compulsory health insurance. Public spending will also grow, albeit at ...
$1,295.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

BMI View: Sustained growth in Bangladesh's pharmaceutical and healthcare market will continue to translate in to commercial opportunities for drugmakers over the forecast period. A large generic medicine segment will continue to account for ...
$1,295.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

BMI View: Government initiatives to boost the nascent domestic pharmaceutical industry and reduce the reliance on imports will limit the attractiveness of Belarus to multinational drugmakers. Government interference, in the form of domestic bias in ...
$1,295.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

BMI View : Governments in developed states such as Belgium will need to work to maintain the countries' long-term attractiveness as sites for clinical trials, especially as the cost of conducting clinical research is forecast to ...
$1,295.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

BMI View: Botswana's pharmaceutical market will continue to present an unattractive investment destination for multinational drugmakers. The country will remain extremely reliant on importing its pharmaceutical needs over our forecast period, as plans to ...
$1,295.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

BMI View: Brazil will continue to be the most important market for multinational pharmaceutical companies in Latin America, d espit e growing financial tensions, increasing pricing pressure and generic competition. Headline Expenditure Projections Pharmaceuticals: BRL65.8 ...
$1,295.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

BMI View: Pharmaceutical companies in Bulgaria will face increased pricing pressures from the National Health Insurance Fund (NHIF) as it unveils more cost-containment measures to rein in pharmaceutical expenditure. The NHIF will increasingly leverage its ...
$1,295.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

BMI View: While the underdeveloped nature of its pharmaceutical and health care sector will bring about commercial benefits for foreign investors, competition from relatively low risk and higher rewards markets such as Vietnam mean s ...
$1,295.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

BMI View : Economic expansion in Cameroon, driven mainly by ambitious investment projects in the infrastructure network, will have a positive effect on overall economic activity and private consumption over the next few years, which will ...
$1,295.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

BMI View: We expect the incoming Liberal government in Canada to implement countercyclical economic measures, which will be beneficial for the pharmaceutical and healthcare sector. Tax breaks and investment in the economy through higher spending ...
$1,295.00
Read More
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

BMI View: Legislative and regulatory improvements to the Central American healthcare system will further strengthen sector coordination, enhancing medical efficiencies and treatments over the long-term. The region's ageing population and dependence on pharmaceutical imports ...
$1,295.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

BMI View : Healthcare service provision in Chile will continue to improve steadily. However, development in the public sector will be held up by limited funding, leaving the private sector to continue to dominate the market ...
$1,295.00
Read More
China Pharmaceuticals & Healthcare Report

China Pharmaceuticals & Healthcare Report

BMI View: The merger of China's new rural cooperative medical scheme with its urban residents basic medical insurance scheme will reshape the country's healthcare landscape. This will have important ramifications for the pharmaceutical ...
$1,295.00
Read More
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward improving health coverage , will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. However, h igh ...
$1,295.00
Read More
Cote d'Ivoire Pharmaceuticals & Healthcare Report

Cote d'Ivoire Pharmaceuticals & Healthcare Report

BMI View: Cote d'Ivoire's pharmaceutical market will remain unattractive for multinational pharmaceutical companies. This is particularly true for innovative drugmakers as the country lacks patent legislation and a reimbursement regime. Furthermore, the country ...
$1,295.00
Read More
Showing
1-20 of 98